- Home
- ARBE vs TVGN Comparison
ARBE vs TVGN Comparison
Compare ARBE & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARBE | TVGN |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 63.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARBE | TVGN |
|---|---|---|
| Price | $0.76 | $8.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $2.38 | N/A |
| AVG Volume (30 Days) | ★ 985.5K | 24.7K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $363.94 | N/A |
| Revenue Next Year | $286.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.14 |
| 52 Week High | $2.88 | $10.76 |
Technical Indicators
Market Signals| Indicator | ARBE | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 70.10 |
| Support Level | $0.76 | $0.47 |
| Resistance Level | $1.46 | $10.76 |
| Average True Range (ATR) | 0.05 | 0.79 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 50.04 | 70.68 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.